Carbon-14 radiolabeling and in vivo biodistribution of a potential anti-TB compound.

about

Carbon-14 radiolabelling and tissue distribution evaluation of a potential anti-TB compound.

P2860

Q40701448-6EB418E3-E23F-430C-9387-ACA8F9D0614C

P2860

Carbon-14 radiolabeling and in vivo biodistribution of a potential anti-TB compound.

Item

http://www.wikidata.org/entity/Q35562944

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Carbon-14 radiolabeling and in vivo biodistribution of a potential anti-TB compound.

@ast

Carbon-14 radiolabeling and in vivo biodistribution of a potential anti-TB compound.

@en

type

Item

label

Carbon-14 radiolabeling and in vivo biodistribution of a potential anti-TB compound.

@ast

Carbon-14 radiolabeling and in vivo biodistribution of a potential anti-TB compound.

@en

prefLabel

Carbon-14 radiolabeling and in vivo biodistribution of a potential anti-TB compound.

@ast

Carbon-14 radiolabeling and in vivo biodistribution of a potential anti-TB compound.

@en

P1476

Carbon-14 radiolabeling and in vivo biodistribution of a potential anti-TB compound.

@en

P2093

Biljana Marjanovic-Painter

http://www.w3.org/2001/XMLSchema#string

Grant Boyle

http://www.w3.org/2001/XMLSchema#string

Jan R Zeevaart

http://www.w3.org/2001/XMLSchema#string

Kobus Venter

http://www.w3.org/2001/XMLSchema#string

Molahlehi S Sonopo

http://www.w3.org/2001/XMLSchema#string

Susan Winks

http://www.w3.org/2001/XMLSchema#string

P2860

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis

Antituberculosis activity of the molecular libraries screening center network library.

Radiosynthesis and bioimaging of the tuberculosis chemotherapeutics isoniazid, rifampicin and pyrazinamide in baboons

Preclinical testing of the nitroimidazopyran PA-824 for activity against Mycobacterium tuberculosis in a series of in vitro and in vivo models.

PA-824 exhibits time-dependent activity in a murine model of tuberculosis.

Progress in TB drug development and what is still needed.

Synthesis and antitubercular activity of 7-(R)- and 7-(S)-methyl-2-nitro-6-(S)-(4-(trifluoromethoxy)benzyloxy)-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazines, analogues of PA-824.

Structure-activity relationships of antitubercular nitroimidazoles. 1. Structural features associated with aerobic and anaerobic activities of 4- and 5-nitroimidazoles

Synthesis and structure-activity relationships of varied ether linker analogues of the antitubercular drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5h-imidazo[2,1-b][1,3]oxazine (PA-824).

Synthesis and structure-activity relationships of antitubercular 2-nitroimidazooxazines bearing heterocyclic side chains.

P304

23-29

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JLCR.3256

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272512869

http://www.w3.org/2001/XMLSchema#string

P698

25689967

http://www.w3.org/2001/XMLSchema#string

Carbon-14 radiolabeling and in vivo biodistribution of a potential anti-TB compound.

about

P2860

P2860

Carbon-14 radiolabeling and in vivo biodistribution of a potential anti-TB compound.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698